Seattle, WA, United States of America

Eric Alan Butz

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovations of Eric Alan Butz: Pioneering T-Regulatory Cell Expansion

Introduction: Eric Alan Butz, an innovative inventor based in Seattle, Washington, has made significant contributions to the field of biotechnology. With a total of two patents to his name, Butz is dedicated to advancing medical research and applications in immunology. His work at Amgen Inc. focuses on groundbreaking methods that enhance the expansion and activation of T regulatory cells, crucial for various therapeutic applications.

Latest Patents: Butz's latest patents are particularly noteworthy for their specificity and potential impact. His patents, titled "Interleukin-2 muteins for the expansion of T-regulatory cells," detail innovative IL-2 muteins and IL-2 mutein Fc-fusion molecules that not only preferentially expand and activate T regulatory cells but are also designed for large-scale production. These inventions include anti-IL-2 antibodies and complexes that improve the efficacy of treatments involving T regulatory cells. Additionally, Butz's patents describe variant human IgG1 Fc molecules that maintain high stability while reducing effector function despite lacking glycosylation at N297. The inclusion of linker peptides that can be glycosylated when expressed in mammalian cells further highlights the sophisticated nature of his work, which could lead to significant advancements in immune system therapies.

Career Highlights: Throughout his career at Amgen Inc., Eric Alan Butz has showcased his dedication to scientific innovation. His work in biotechnology emphasizes the importance of immunology research and the development of therapies aimed at enhancing immune system responses. With his contributions published in influential scientific literature, Butz has established himself as a respected figure in his field.

Collaborations: Eric Alan Butz has collaborated with talented professionals such as Christy Ann Thomson and Ian Nevin Foltz. Together, they contribute to the ongoing progress in the biotechnology sector, particularly within the realm of immunological research and cellular therapies.

Conclusion: In conclusion, Eric Alan Butz is an exemplary inventor whose work has the potential to transform the understanding and treatment of immune-related diseases. With his inventive spirit and dedication to research, Butz continues to be an influential presence in the biotechnology industry, driving forward the boundaries of what is possible in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…